Omega Fund Management, LLC
- SEC CIK
- 0001637359
- Latest filing
- Aug 14, 2026
Holdings in Q2 2022
Holdings as of Jun 30, 2022, filed Aug 15, 2022. Long positions only; changes compare share counts with Q1 2022.
- Positions
- 21
- −1 vs. Q1 2022
- Portfolio value
- $313.3M
- −$175.3M (−35.9%) vs. Q1 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| REPLReplimune Group, Inc. | COM | 4,673,380 | $81.7M | 26.1% | 00.0% | Unchanged | History |
| NUVBNuvation Bio Inc. | COM CL A | 15,247,340 | $49.4M | 15.8% | −7,710,000−33.6% | Reduced | History |
| IMGOImago BioSciences, Inc. | COM | 3,018,737 | $40.4M | 12.9% | 00.0% | Unchanged | History |
| MORFMorphic Holding, Inc. | COM | 1,010,769 | $21.9M | 7.0% | −189,245−15.8% | Reduced | History |
| CINCCinCor Pharma, Inc. | COM | 966,176 | $18.2M | 5.8% | 00.0% | Unchanged | History |
| ALPNAlpine Immune Sciences, Inc. | COM | 2,029,580 | $17.3M | 5.5% | 00.0% | Unchanged | History |
| KRONKronos Bio, Inc. | COM | 3,818,283 | $13.9M | 4.4% | 00.0% | Unchanged | History |
| ARQTArcutis Biotherapeutics, Inc. | COM | 623,836 | $13.3M | 4.2% | 00.0% | Unchanged | History |
| GOSSGossamer Bio, Inc. | COM | 1,500,000 | $12.6M | 4.0% | −1,664,835−52.6% | Reduced | History |
| IMAImageneBio, Inc. | COM | 2,249,123 | $9.96M | 3.2% | 00.0% | Unchanged | History |
| IMUXImmunic, Inc. | COM | 1,788,160 | $6.21M | 2.0% | 00.0% | Unchanged | History |
| SANASana Biotechnology, Inc. | COM | 843,750 | $5.42M | 1.7% | 00.0% | Unchanged | History |
| Omega Alpha SpacG6749V107 | CL A | 501,000 | $4.93M | 1.6% | 00.0% | Unchanged | – |
| THRXTheseus Pharmaceuticals, Inc. | COM | 711,479 | $3.93M | 1.3% | 00.0% | Unchanged | History |
| PRTKParatek Pharmaceuticals, Inc. | COM | 1,971,241 | $3.80M | 1.2% | 00.0% | Unchanged | History |
| SPRBSpruce Biosciences, Inc. | COM | 2,161,022 | $3.76M | 1.2% | 00.0% | Unchanged | History |
| SYRSSyros Pharmaceuticals, Inc. | COM | 2,512,705 | $2.42M | 0.8% | 00.0% | Unchanged | History |
| IMCRImmunocore Holdings plc | ADS | 51,535 | $1.92M | 0.6% | 00.0% | Unchanged | History |
| EPIXESSA Pharma Inc. | COM NEW | 328,196 | $1.03M | 0.3% | 00.0% | Unchanged | History |
| JNCEJounce Therapeutics, Inc. | COM | 275,513 | $835.0K | 0.3% | 00.0% | Unchanged | History |
| SNTISenti Biosciences Holdings, Inc. | COM | 195,792 | $386.0K | 0.1% | +195,792 | New | History |
Sold out since Q1 2022 (2)
Positions held at the end of Q1 2022 that are gone from this filing.